Issue 16, 2006

New polyethyleneglycol-functionalized texaphyrins: synthesis and in vitro biological studies

Abstract

The synthesis of four new analogues of motexafin gadolinium (MGd), a gadolinium(III) texaphyrin complex in clinical trials for its anticancer properties, is described. These new derivatives contain either 1,2-diaminobenzene or 2,3-diaminonaphthalene subunits as the source of the imine nitrogens and bear multiple 2-[2-(2-methoxyethoxy)ethoxy]ethoxy (PEG) groups, on either meso aryl or beta-pyrrolic substituents, to increase their water solubility. All four analogues were found to be more active in vitro than the parent system MGd as judged from cell proliferation assays using the PC3 and A549 cell lines.

Graphical abstract: New polyethyleneglycol-functionalized texaphyrins: synthesis and in vitro biological studies

Supplementary files

Article information

Article type
Paper
Submitted
04 Nov 2005
Accepted
17 Jan 2006
First published
24 Jan 2006

Dalton Trans., 2006, 1934-1942

New polyethyleneglycol-functionalized texaphyrins: synthesis and in vitro biological studies

W. Wei, Z. Wang, T. Mizuno, C. Cortez, L. Fu, M. Sirisawad, L. Naumovski, D. Magda and J. L. Sessler, Dalton Trans., 2006, 1934 DOI: 10.1039/B515636J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements